← All trials
NCT06182176
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2024
- Primary completion
- Nov 29, 2024
- Completion date
- Jan 12, 2026
- First posted
- Dec 26, 2023
- Last posted
- Dec 26, 2023
- Enrollment
- 1200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
- University of LondonStudy director
- Kintampo Health Research Centre, GhanaCollaborator
- Kintampo Health Research Centre, GhanaStudy chair
- Kintampo Health Research Centre, GhanaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.